ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $8,304,000 | -9.4% | 667,499 | -0.3% | 0.01% | -9.1% |
Q3 2016 | $9,168,000 | +86.6% | 669,672 | +0.7% | 0.01% | +83.3% |
Q2 2016 | $4,913,000 | +30.7% | 664,847 | +13.0% | 0.01% | +20.0% |
Q1 2016 | $3,759,000 | +6.7% | 588,332 | +4.4% | 0.01% | 0.0% |
Q4 2015 | $3,522,000 | +7.3% | 563,474 | +0.3% | 0.01% | +25.0% |
Q3 2015 | $3,281,000 | -30.1% | 561,742 | -1.1% | 0.00% | -33.3% |
Q2 2015 | $4,697,000 | +25.0% | 567,997 | +24.5% | 0.01% | +20.0% |
Q1 2015 | $3,759,000 | +21.9% | 456,151 | +1.6% | 0.01% | +25.0% |
Q4 2014 | $3,084,000 | +25.9% | 448,920 | -1.0% | 0.00% | +33.3% |
Q3 2014 | $2,449,000 | -14.8% | 453,585 | +0.5% | 0.00% | -25.0% |
Q2 2014 | $2,875,000 | +473.9% | 451,299 | +626.4% | 0.00% | +300.0% |
Q1 2014 | $501,000 | +16.5% | 62,127 | -1.4% | 0.00% | 0.0% |
Q4 2013 | $430,000 | -86.2% | 63,037 | -62.7% | 0.00% | -80.0% |
Q3 2013 | $3,106,000 | +132.3% | 168,791 | +120.8% | 0.01% | +150.0% |
Q2 2013 | $1,337,000 | – | 76,434 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |